CR2
protein-codingcomplement C3d receptor 2, the group of CD molecules|Sushi domain containing|Complement system regulators and receptors
Gene summary
This gene encodes a membrane protein, which functions as a receptor for Epstein-Barr virus (EBV) binding on B and T lymphocytes. Genetic variations in this gene are associated with susceptibility to systemic lupus erythematosus type 9 (SLEB9). Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Sep 2009]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~36.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: Unknown
Disease ID:MONDO:0007915
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0013862
Submitter: ClinGen
CR2, also referred to as CD21, was first reported in relation to autosomal recessive common variable immunodeficiency (CVID; OMIM # 614699) in 2012 (Thiel J et al., PMID: 22035880). CR2-associated CVID is a heterogeneous disorder characterized by hypogammaglobulinemia with some patients also presenting with recurrent infections, particularly respiratory infections. Importantly, individuals carrying biallelic pathogenic CR2 variants may present with the immunological phenotype of hypogammaglobulinemia and low levels of class-switched B cells in the absence of a clinical phenotype, such as recurrent infections (PMID: 30075290). It is currently unknown what proportion of affected individuals are currently asymptomatic or how likely they are to present with a clinical phenotype at a later age. Five variants (nonsense, frameshift, and canonical splice site) found that have been reported in three unrelated probands (and four probands total) as either compound heterozygous or homozygous in three publications are included in this curation (PMIDs: 22035880, 26325596, 28499783). The mechanism of pathogenicity appears to be loss of function. This gene-disease association is also supported by animal models, expression studies, and in vitro functional assays (PMIDs: 6234356, 8622941, 8624815, 1702139, 12479818, 22035880, 26325596). CR2 has been shown to be expressed on the majority of circulating mature human B cells and human follicular dendritic cells (PMID: 6234356, 2471772) and is part of the B-cell receptor complex (PMID: 1702139). CD19 (as well as CD81) is also a member of the B-cell receptor complex and has also been associated with common variable immunodeficiency (OMIM # 613493). Mouse models lacking expression of CR2/CR1 have decreased levels of antibody, particularly IgG, and have increased susceptibility to infection (PMIDs: 8622941, 8624815, 12479818). Expression of human CR2 in CR2/CR1-/- mice rescues secondary responses to T-dependent antigen in CR2/CR1-/- mice (PMID: 21269698). B cells from patients with CR2-associated CVID decreased responses to antigen and AID expression (PMIDs: 22035880, 26325596). In summary, CR2 is definitively associated with autosomal recessive CVID. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. Notably, this curation does not assess the reported relationship between CR2 and susceptibility to systemic lupus erythematosus (OMIM # 610927).
Inheritance Pattern: AR
Disease ID:MONDO:0013862
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0013862
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Allergy/Immunology/Infectious
Intervention: Allergy/Immunology/Infectious
Rationale: Antiinfectious prophylaxis and early and aggressive treatment of infections may be beneficial
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CR2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001006658.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 4 | 203 | 4 | 211 | ||
| missense | 3 | 406 | 36 | 1 | 446 | |
| nonsense | 19 | 12 | 31 | |||
| start loss | 0 | |||||
| frameshift | 17 | 9 | 2 | 28 | ||
| splice donor/acceptor (+/-2bp) | 2 | 9 | 11 | |||
| Total | 38 | 33 | 412 | 239 | 5 | 727 |
Highest pathogenic variant AF is 0.00088153355
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001006659.1 | 19 | MANE Select | |
| Ensembl | ENSP00000356024.3 | 19 | MANE Select | |
| RefSeq | NP_001868.2 | 18 | Standard | |
| Ensembl | ENSP00000356025.3 | 18 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Complement and coagulation cascades - Homo sapiens (human)
- B cell receptor signaling pathway - Homo sapiens (human)
- Hematopoietic cell lineage - Homo sapiens (human)
- Epstein-Barr virus infection - Homo sapiens (human)
- B Cell Receptor Signaling Pathway
Biological Process
- complement receptor mediated signaling pathway
- immune response
- complement activation, classical pathway
- B cell differentiation
- regulation of complement activation
Molecular Function
- virus receptor activity
- complement binding
- DNA binding
- complement receptor activity
- transmembrane signaling receptor activity
Cellular Component
- plasma membrane
- integral component of membrane
- receptor complex
- extracellular exosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000367057
- Coding exons
- 19
- Length
- 35666
- Individuals with no LoFs
- 125652
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 94
- Defined
- 125746
- p
- 0.000374
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.793 | 542 | 597 | 0.909 | 0.0000315 | 7113 |
| Missense (PolyPhen) | 155 | 192.61 | 0.80474 | 2351 | ||
| Synonymous | -0.549 | 221 | 211 | 1.05 | 0.0000112 | 2151 |
| Loss of Function | 2.29 | 38 | 56.6 | 0.671 | 0.00000334 | 660 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00031 | 0.00031 | rare |
| Latino/Admixed American | 0.00020 | 0.00020 | rare |
| Ashkenazi Jewish | 0.00010 | 0.000099 | rare |
| East Asian | 0.0014 | 0.0014 | notable |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00041 | 0.00040 | rare |
| South Asian | 0.00023 | 0.00023 | rare |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Receptor for complement C3Dd, for the Epstein-Barr virus on human B-cells and T-cells and for HNRNPU (PubMed:7753047). Participates in B lymphocytes activation (PubMed:7753047). {ECO:0000269|PubMed:7753047}.;
- Disease
- DISEASE: Immunodeficiency, common variable, 7 (CVID7) [MIM:614699]: A primary immunodeficiency characterized by antibody deficiency, hypogammaglobulinemia, recurrent bacterial infections and an inability to mount an antibody response to antigen. The defect results from a failure of B-cell differentiation and impaired secretion of immunoglobulins; the numbers of circulating B-cells is usually in the normal range, but can be low. {ECO:0000269|PubMed:22035880}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.458
Intolerance Scores
- LoFtool
- 0.952
- RVIS EVS
- 0.06
- RVIS percentile EVS
- 57.56
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.558
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | High | High | High |
| Primary Immunodeficiency | High | High | High |
| Cancer | High | High | High |